Savara SVRA Stock
5.07 USD
{{ price }}
-5.056180%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
700.41M USD
LOW - HIGH [24H]
5
-
5.33 USD
VOLUME [24H]
1.18M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.33 USD
Savara Price Chart
Savara SVRA Financial and Trading Overview
| Savara stock price | 5.07 USD |
| Previous Close | 3.2 USD |
| Open | 3.2 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 3.16 - 3.31 USD |
| 52 Week Range | 1.08 - 3.4 USD |
| Volume | 730.06K USD |
| Avg. Volume | 273.91K USD |
| Market Cap | 362.73M USD |
| Beta (5Y Monthly) | 0.836971 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.6 USD |
SVRA Valuation Measures
| Enterprise Value | 276.24M USD |
| Trailing P/E | N/A |
| Forward P/E | -11.357143 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.6933799 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.633 |
Trading Information
Savara Stock Price History
| Beta (5Y Monthly) | 0.836971 |
| 52-Week Change | 144.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.4 USD |
| 52 Week Low | 1.08 USD |
| 50-Day Moving Average | 2.27 USD |
| 200-Day Moving Average | 1.88 USD |
SVRA Share Statistics
| Avg. Volume (3 month) | 273.91K USD |
| Avg. Daily Volume (10-Days) | 657.97K USD |
| Shares Outstanding | 114.07M |
| Float | 44.54M |
| Short Ratio | 2.73 |
| % Held by Insiders | 1.93% |
| % Held by Institutions | 70.66% |
| Shares Short | 740.96K |
| Short % of Float | 0.85% |
| Short % of Shares Outstanding | 0.64% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.62% |
| Return on Equity (ttm) | -34.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -41646000 USD |
| Net Income Avi to Common (ttm) | -40407000 USD |
| Diluted EPS (ttm) | -0.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 115.02M USD |
| Total Cash Per Share (mrq) | 1.01 USD |
| Total Debt (mrq) | 26.25M USD |
| Total Debt/Equity (mrq) | 26.71 USD |
| Current Ratio (mrq) | 23.898 |
| Book Value Per Share (mrq) | 0.861 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38155000 USD |
| Levered Free Cash Flow (ttm) | -22357124 USD |
Profile of Savara
| Country | United States |
| State | TX |
| City | Austin |
| Address | Building III |
| ZIP | 78746 |
| Phone | 512 614 1848 |
| Website | https://www.savarapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.
Q&A For Savara Stock
What is a current SVRA stock price?
Savara SVRA stock price today per share is 5.07 USD.
How to purchase Savara stock?
You can buy SVRA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Savara?
The stock symbol or ticker of Savara is SVRA.
Which industry does the Savara company belong to?
The Savara industry is Biotechnology.
How many shares does Savara have in circulation?
The max supply of Savara shares is 138.15M.
What is Savara Price to Earnings Ratio (PE Ratio)?
Savara PE Ratio is now.
What was Savara earnings per share over the trailing 12 months (TTM)?
Savara EPS is -0.33 USD over the trailing 12 months.
Which sector does the Savara company belong to?
The Savara sector is Healthcare.
Savara SVRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}